Atlas Private Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Atlas Private Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,564	Closed	-$395K	–	157
2025 Q2	$395K	Sell	3,564 -496	-12%	-$52.8K	0.05%	133
2025 Q1	$455K	Sell	4,060 -3,707	-48%	-$383K	0.06%	116
2024 Q4	$717K	Sell	7,767 -573	-7%	-$51.6K	0.1%	86
2024 Q3	$699K	Buy	8,340 +736	+10%	+$56.2K	0.1%	83
2024 Q2	$522K	Buy	+7,604	New	+$507K	0.08%	93
2021 Q4	–	Sell	-477	Closed	-$33K	–	361
2021 Q3	$33K	Buy	477 +2	+0.4%	+$141	0.02%	280
2021 Q2	$33K	Sell	475 -471	-50%	-$31.4K	0.02%	281
2021 Q1	$61K	Buy	946 +404	+75%	+$26.1K	0.03%	213
2020 Q4	$32K	Hold	542	–	–	0.02%	275
2020 Q3	$34K	Sell	542 -159	-23%	-$11K	0.03%	247
2020 Q2	$54K	Buy	+701	New	+$53.7K	0.05%	194

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Atlas Private Wealth Advisors's GILD Position: Q3 2025 in Review

Atlas Private Wealth Advisors sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 3,564 shares — an estimated $395K sold.

Atlas Private Wealth Advisors first reported a position in GILD in Q2 2020 and held it in 11 quarters. The position peaked at $717K in Q4 2024. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

Atlas Private Wealth Advisors reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
Atlas Private Wealth Advisors sold 3,564 Gilead Sciences shares in Q3 2025, an estimated $395K.
Atlas Private Wealth Advisors first reported a position in Gilead Sciences in Q2 2020 and held it in 11 quarters.
Atlas Private Wealth Advisors's Gilead Sciences position peaked at $717K in Q4 2024.
2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Atlas Private Wealth Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.